ArticleJournal of neuro-oncology2015
Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma.
Lei Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it